Monoamine oxidase inhibitors (MAOI) are regarded to prolong and greatly enhance the consequences of dimethyltryptamine (copyright) and one particular research assumed the impact on psilocybin might be very similar because it is actually a structural analogue of copyright.[a hundred forty five] Having said that, only a small percentage of psilocin a